These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 18225550)

  • 1. The inhibitory effect of docetaxel and p38 MAPK inhibitor on TZT-1027 (Soblidotin)-induced antivascular activity.
    Watanabe J; Natsume T; Kobayashi M
    Anticancer Res; 2007; 27(6B):3909-18. PubMed ID: 18225550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the antivascular and cytotoxic activities of TZT-1027 (Soblidotin) with those of other anticancer agents.
    Watanabe J; Natsume T; Kobayashi M
    Anticancer Drugs; 2007 Sep; 18(8):905-11. PubMed ID: 17667596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antivascular effects of TZT-1027 (Soblidotin) on murine Colon26 adenocarcinoma.
    Watanabe J; Natsume T; Kobayashi M
    Cancer Sci; 2006 Dec; 97(12):1410-6. PubMed ID: 16999818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of p38 mitogen-activated protein kinase enhances c-Jun N-terminal kinase activity: implication in inducible nitric oxide synthase expression.
    Lahti A; Sareila O; Kankaanranta H; Moilanen E
    BMC Pharmacol; 2006 Feb; 6():5. PubMed ID: 16504051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiangiogenic activity of TZT-1027 (soblidotin) on chick chorioallantoic membrane and human umbilical vein endothelial cells.
    Watanabe J; Endo Y; Shimada N; Natsume T; Sasaki T; Kobayashi M
    In Vivo; 2007; 21(2):297-304. PubMed ID: 17436580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TZT-1027 elucidates antitumor activity through direct cytotoxicity and selective blockade of blood supply.
    Hashiguchi N; Kubota T; Koh J; Yamada Y; Saikawa Y; Otani Y; Watanabe M; Kumai K; Kitajima M; Watanabe J; Kobayashi M
    Anticancer Res; 2004; 24(4):2201-8. PubMed ID: 15330161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin inhibits tissue factor expression and enhances tissue factor pathway inhibitor expression in human endothelial cells.
    Chen YJ; Zhang LQ; Wang GP; Zeng H; Lü B; Shen XL; Jiang ZP; Chen FP
    Thromb Haemost; 2008 Aug; 100(2):291-300. PubMed ID: 18690350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitor of p42/44 mitogen-activated protein kinase, but not p38 MAPK, attenuated antigen challenge of guinea pig airways in vitro.
    Chue SC; Seow CJ; Duan W; Yeo KS; Koh AH; Wong WS
    Int Immunopharmacol; 2004 Aug; 4(8):1089-98. PubMed ID: 15222984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TZT-1027, an antimicrotubule agent, attacks tumor vasculature and induces tumor cell death.
    Otani M; Natsume T; Watanabe JI; Kobayashi M; Murakoshi M; Mikami T; Nakayama T
    Jpn J Cancer Res; 2000 Aug; 91(8):837-44. PubMed ID: 10965026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p38 MAPK inhibitors ameliorate target organ damage in hypertension: Part 1. p38 MAPK-dependent endothelial dysfunction and hypertension.
    Ju H; Behm DJ; Nerurkar S; Eybye ME; Haimbach RE; Olzinski AR; Douglas SA; Willette RN
    J Pharmacol Exp Ther; 2003 Dec; 307(3):932-8. PubMed ID: 14561851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of TZT-1027 (Soblidotin).
    Watanabe J; Minami M; Kobayashi M
    Anticancer Res; 2006; 26(3A):1973-81. PubMed ID: 16827132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of TZT-1027 (Soblidotin) against vascular endothelial growth factor-secreting human lung cancer in vivo.
    Natsume T; Watanabe J; Koh Y; Fujio N; Ohe Y; Horiuchi T; Saijo N; Nishio K; Kobayashi M
    Cancer Sci; 2003 Sep; 94(9):826-33. PubMed ID: 12967483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-specific antivascular effect of TZT-1027 (Soblidotin) elucidated by magnetic resonance imaging and confocal laser scanning microscopy.
    Natsume T; Watanabe J; Ogawa K; Yasumura K; Kobayashi M
    Cancer Sci; 2007 Apr; 98(4):598-604. PubMed ID: 17284247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK.
    Tanikawa T; Okada Y; Tanikawa R; Tanaka Y
    J Vasc Res; 2009; 46(6):572-80. PubMed ID: 19571577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of MAPKs in endostatin-mediated regulation of blood-retinal barrier function.
    Campbell M; Collery R; McEvoy A; Gardiner TA; Stitt AW; Brankin B
    Curr Eye Res; 2006 Dec; 31(12):1033-45. PubMed ID: 17169842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cadherin modulates endothelial barrier function.
    Andreeva AV; Han J; Kutuzov MA; Profirovic J; Tkachuk VA; Voyno-Yasenetskaya TA
    J Cell Physiol; 2010 Apr; 223(1):94-102. PubMed ID: 20039275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuated expression of the tight junction proteins is involved in clopidogrel-induced gastric injury through p38 MAPK activation.
    Wu HL; Gao X; Jiang ZD; Duan ZT; Wang SK; He BS; Zhang ZY; Xie HG
    Toxicology; 2013 Feb; 304():41-8. PubMed ID: 23220562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cadmium induces vascular permeability via activation of the p38 MAPK pathway.
    Dong F; Guo F; Li L; Guo L; Hou Y; Hao E; Yan S; Allen TD; Liu J
    Biochem Biophys Res Commun; 2014 Jul; 450(1):447-52. PubMed ID: 24909688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p38 MAPK downregulates phosphorylation of Bad in doxorubicin-induced endothelial apoptosis.
    Grethe S; Coltella N; Di Renzo MF; Pörn-Ares MI
    Biochem Biophys Res Commun; 2006 Sep; 347(3):781-90. PubMed ID: 16843435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The low molecular weight fraction of commercial human serum albumin induces acetylation of α-tubulin and reduces transcytosis in retinal endothelial cells.
    Thomas GW; Rael LT; Hausburg M; Frederick ED; Brody E; Bar-Or D
    Biochem Biophys Res Commun; 2016 Sep; 478(4):1780-5. PubMed ID: 27613088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.